BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32861555)

  • 21. The Therapeutic Benefit of Radical Resection for T4b Oral Cavity Squamous Cell Carcinoma with Partial or Complete Response After Radical Chemo-Intensity-Modulated Radiotherapy (IMRT).
    Fang FM; Chuang HC; Chou SY; Huang TL; Wang CJ; Lin YT; Chiu TJ; Lin WC; Li SH; Su YY; Chien CY
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):866-873. PubMed ID: 27613559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study.
    Kang CJ; Wen YW; Lee SR; Ng SH; Lee LA; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Tsai CY; Lin CH; Tsao CK; Fang TJ; Huang SF; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
    Oral Oncol; 2022 Mar; 126():105750. PubMed ID: 35123256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction chemotherapy in locally advanced T4b oral cavity squamous cell cancers: A regional cancer center experience.
    Rudresha AH; Chaudhuri T; Lakshmaiah KC; Babu KG; Dasappa L; Jacob LA; Suresh Babu MC; Lokesh KN; Rajeev LK
    Indian J Cancer; 2017; 54(1):35-38. PubMed ID: 29199659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative outcomes in oral cavity cancer with resected pT4a and pT4b.
    Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Ng SH; Lin CH; Tsao CK; Chen IH; Chang KP; Huang SF; Kang CJ; Fang KH; Wang YC; Chang YL; Huang YC; Tsai CY; Yen TC
    Oral Oncol; 2013 Mar; 49(3):230-6. PubMed ID: 23063612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
    Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI
    Cochrane Database Syst Rev; 2011 Apr; (4):CD006386. PubMed ID: 21491393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
    Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI;
    Cochrane Database Syst Rev; 2010 Sep; (9):CD006386. PubMed ID: 20824847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irradiation for locoregionally recurrent, never-irradiated oral cavity cancers.
    Lok BH; Chin C; Riaz N; Ho F; Hu M; Hong JC; Shi W; Zhang Z; Sherman E; Wong RJ; Morris LG; Ganly I; Wolden SL; Rao SS; Lee NY
    Head Neck; 2015 Nov; 37(11):1633-41. PubMed ID: 24954094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological tailoring of adjuvant radiotherapy in head and neck and oral malignancies - The potential role of p53 and eIF4E as predictive parameters.
    Joseph B; Kumar RV; Champaka G; Shenoy A; Sabitha KS; Lokesh V; Ramesh C; Vijay CR
    Indian J Cancer; 2019; 56(4):330-334. PubMed ID: 31607702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RE: Impact of radical treatments on survival in locally advanced T4a and T4b buccal mucosa cancers: Selected surgically treated T4b cancers have similar control rates as T4a.
    Shetty SS; Vishal Rao US
    Oral Oncol; 2019 Mar; 90():122. PubMed ID: 30678995
    [No Abstract]   [Full Text] [Related]  

  • 30. The importance of lymph node ratio for patients with mandibular infiltration of oral squamous cell carcinoma.
    Safi AF; Kauke M; Grandoch A; Nickenig HJ; Zöller J; Kreppel M
    J Craniomaxillofac Surg; 2018 Jun; 46(6):1007-1012. PubMed ID: 29709331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should radiological staging of advanced buccal mucosa cancer preclude curative intent treatment? A prospective evaluation.
    Munnangi A; Kadapathri A; Pillai V; Shetty V; Rangappa V; Subramaniam N
    Oral Oncol; 2021 Aug; 119():105246. PubMed ID: 33663918
    [No Abstract]   [Full Text] [Related]  

  • 33. Management for squamous cell carcinoma of the nasal cavity and ethmoid sinus: A single institution experience.
    Homma A; Nakamaru Y; Sakashita T; Onimaru R; Terasaka S; Tsuchiya K; Yoshida D; Yasuda K; Hatakeyama H; Furusawa J; Mizumachi T; Kano S; Shirato H; Fukuda S
    Auris Nasus Larynx; 2015 Oct; 42(5):377-81. PubMed ID: 25748513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of perineural invasion in locally advanced bucco alveolar complex carcinomas treated with surgery and postoperative radiation ± concurrent chemotherapy.
    Anand AK; Agarwal P; Gulia A; Goel V; Jain J; Chaturvedi H; Hazarika B; Mukherjee U; Arora D; Bansal AK
    Head Neck; 2017 Jul; 39(7):1446-1453. PubMed ID: 28452191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Lymphovascular Space Invasion With Locoregional Failure and Survival in Patients With Node-Negative Oral Tongue Cancers.
    Cassidy RJ; Switchenko JM; Jegadeesh N; Sayan M; Ferris MJ; Eaton BR; Higgins KA; Wadsworth JT; Magliocca KR; Saba NF; Beitler JJ
    JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):382-388. PubMed ID: 28097311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcome and prognostic factors in recurrent oral squamous cell carcinoma after primary surgical treatment: a retrospective study.
    Zittel S; Moratin J; Horn D; Metzger K; Ristow O; Engel M; Mrosek J; Freier K; Hoffmann J; Freudlsperger C
    Clin Oral Investig; 2022 Feb; 26(2):2055-2064. PubMed ID: 34581884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a role of induction chemotherapy followed by resection in T4b oral cavity cancers?
    Joshi A; Patil VM; Noronha V; Juvekar S; Deshmukh A; Chatturvedi P; Chaukar DA; Agarwal JP; Ghosh S; Murthy V; D'cruz A; Prabhash K
    Indian J Cancer; 2013; 50(4):349-55. PubMed ID: 24369216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of patients with clinically lymph node-negative squamous cell carcinoma of the oral cavity.
    Jang WI; Wu HG; Park CI; Kim KH; Sung MW; Kim MJ; Choung PH; Lee JH; Choi JY
    Jpn J Clin Oncol; 2008 Jun; 38(6):395-401. PubMed ID: 18573849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of selective neck dissection (I-III) in the treatment of node negative (N0) neck in oral cancer.
    Iype EM; Sebastian P; Mathew A; Balagopal PG; Varghese BT; Thomas S
    Oral Oncol; 2008 Dec; 44(12):1134-8. PubMed ID: 18486527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant Superselective Intra-Arterial Cisplatin Chemoradiotherapy Combined With Surgery in Patients With T4 Squamous Cell Carcinoma of the Maxillary Sinus.
    Ikeda M; Suzuki M; Matsuzuka T; Ishii S; Sato H; Murono S
    J Oral Maxillofac Surg; 2022 Aug; 80(8):1445-1450. PubMed ID: 35636468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.